SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 12th, 2020 • Genetic Technologies LTD • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of ______ __, 2020, between Genetic Technologies Limited, an Australian corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
PLACEMENT AGENT AMERICAN DEPOSITARY SHARES PURCHASE WARRANT geneTIC technologies LIMITEDGenetic Technologies LTD • May 12th, 2020 • Biological products, (no disgnostic substances) • New York
THIS PLACEMENT AGENT AMERICAN DEPOSITARY SHARES PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on _______ __, _____ (the “Termination Date”), but not thereafter, to subscribe for and purchase from Genetic Technologies Limited, an Australian corporation (the “Company”), up to ______ American Depositary Shares (“ADSs”), each ADS representing six hundred (600) ordinary shares, no par value, of the Company (the “Ordinary Shares”) (as subject to adjustment hereunder, the “Warrant Shares”) (the ADSs issuable hereunder, the “Warrant ADSs”). The purchase price of one ADS under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain
